Ignite Creation Date:
2024-05-05 @ 4:49 PM
Last Modification Date:
2024-10-26 @ 9:24 AM
Study NCT ID:
NCT00321620
Status:
COMPLETED
Last Update Posted:
2018-08-29
First Post:
2006-05-02
Brief Title:
Study of Denosumab vs Zoledronic Acid to Treat Bone Metastases in Men With Hormone-refractory Prostate Cancer
Sponsor:
Amgen
Organization:
Amgen
Organization Data
Organization:
Amgen
Class:
INDUSTRY
Study ID:
20050103
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Amgen
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None